North America Critical Care Equipment Market
Размер рынка в млрд долларов США
CAGR :
% 
 Прогнозируемый период |
2024 –2030 |
 Размер рынка (базовый год) |
|
 Размер рынка (прогнозируемый год) |
|
 CAGR |
% |
| Основные игроки рынка |
Рынок оборудования для интенсивной терапии в Северной Америке по типу продукции (терапевтические устройства, устройства для мониторинга состояния пациентов, диагностические устройства, отделения и системы интенсивной терапии и другие устройства), популяция пациентов (неонатальные, педиатрические, взрослые и гериатрические), конечный пользователь (больницы, специализированные клиники, амбулаторные хирургические центры и другие), канал сбыта (прямые тендеры, розничные продажи, сторонняя дистрибуция и другие). Тенденции отрасли и прогноз до 2030 года.
Анализ и аналитика рынка оборудования для интенсивной терапии в Северной Америке
Пациенты могут оказаться в отделении интенсивной терапии по разным причинам, но всех их объединяет то, что им требуется пристальное внимание и наблюдение, а также современное оборудование, часто средства жизнеобеспечения и респираторная поддержка.
Рынок оборудования для интенсивной терапии в Северной Америке растет колоссальными темпами из-за роста хронических заболеваний, таких как диабет, сердечно-сосудистые заболевания и заболевания почек среди прочих, что приводит к увеличению числа пациентов, находящихся в отделениях интенсивной терапии. Однако строгие правила и слабая политика возмещения расходов могут сдерживать рынок в течение прогнозируемого периода. Более того, высокая стоимость оборудования для интенсивной терапии является одним из наиболее существенных факторов, которые могут помешать росту рынка в долгосрочной перспективе.
Развитие технологий является возможностью для ключевых игроков в прогнозируемый период. С другой стороны, отсутствие надлежащего кадрового обеспечения и обучения выступает в качестве вызова для роста рынка.
Data Bridge Market Research анализирует, что рынок оборудования для интенсивной терапии в Северной Америке, как ожидается, достигнет значения 32 864,78 млн долларов США к 2030 году при среднегодовом темпе роста 8,8% в прогнозируемый период. Тип продукта составляет самый большой сегмент типа на рынке из-за быстрого спроса на оборудование для интенсивной терапии в Северной Америке. Этот отчет о рынке также подробно охватывает анализ цен, патентный анализ и технологические достижения.
|
Отчет Метрика |
Подробности |
|
Прогнозируемый период |
2023-2030 |
|
Базовый год |
2022 |
|
Исторические годы |
2021 (можно настроить на 2020-2016) |
|
Количественные единицы |
Доход в млн. долл. США, объемы в единицах, цены в долл. США |
|
Охваченные сегменты |
По типу продукции (терапевтические устройства, устройства для мониторинга состояния пациентов, диагностические устройства, отделения и системы интенсивной терапии и другие устройства), популяция пациентов (неонатальные, педиатрические, взрослые и гериатрические), конечный пользователь (больницы, специализированные клиники, амбулаторные хирургические центры и другие), канал сбыта (прямые тендеры, розничные продажи, сторонняя дистрибуция и другие). |
|
Страны, охваченные |
США, Канада и Мексика. |
|
Охваченные участники рынка |
Koninklijke Philips NV, General Electric Company, COOK MEDICAL LLC, Abbott, Medtronic, Getinge AB, heyer medical AG, Drägerwerk AG & Co. KGaA, ICU Medical, Inc., NIHON KOHDEN CORPORATION., Fresenius Medical Care AG & Co. KGaA, Skanray Technologies Ltd., Boston Scientific Corporation, STERIS, Advin Health Care, Baxter, SS TECHNOMED (P) LTD., SCHILLER, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nonin, Dixion distribution of medical devices GmbH, Masimo и Compumedics Limited и другие. |
Определение рынка
Критическое оборудование необходимо для ухода за пациентами в нормальных рабочих условиях, и его отказ может привести к неминуемому серьезному увечью или смерти пациентов или пользователей. Интенсивная терапия также называется интенсивной терапией. Это тип ухода, который включает в себя лечение и ведение травм и заболеваний, которые являются очень серьезными и могут быть опасными для жизни. Хирургические осложнения, травмы в результате несчастных случаев, тяжелые инфекции и серьезные респираторные проблемы — вот несколько примеров состояний, которые могут потребовать интенсивной терапии.
Пациенты, получающие этот уровень ухода, могут выздороветь и перейти на другие виды ухода, но многие люди умирают в отделении интенсивной терапии. Оборудование, используемое для интенсивной терапии, известно как оборудование для интенсивной терапии, которое включает в себя устройства для мониторинга пациентов, блоки и системы интенсивной терапии, а также терапевтические устройства среди прочего. Отделение интенсивной терапии или отделение интенсивной терапии (ОИТ) — это узкоспециализированное и выделенное подразделение больницы для пациентов, которым требуется интенсивный мониторинг медицинских, хирургических и других услуг по уходу за пациентами. Интенсивная терапия осуществляется в отделении интенсивной терапии, которое в некоторых местах называется отделением интенсивной терапии.
Динамика рынка оборудования для интенсивной терапии в Северной Америке
В этом разделе рассматривается понимание движущих сил рынка, преимуществ, возможностей, ограничений и проблем. Все это подробно обсуждается ниже:
Драйверы
- Рост распространенности хронических заболеваний
Изменение привычек образа жизни, таких как курение табака, употребление спиртных напитков, малоподвижный образ жизни и многие другие, увеличили количество случаев, когда пациенты испытывают постоянное недомогание. Растущая распространенность хронических заболеваний стимулирует рынок и положительно влияет на рынок оборудования для интенсивной терапии.
- Рост численности гериатрического населения
Расширение проблем с болезнями наряду с быстро растущим гериатрическим населением существенно повлияет на рынок оборудования для интенсивной терапии. Кроме того, гериатрическое население уязвимо и имеет мало непреодолимых и постоянных болезней. Рост гериатрического населения положительно повлияет на рынок и станет движущей силой роста рынка оборудования для интенсивной терапии.
Сдержанность
- Нехватка квалифицированных специалистов
The lack of capable laboratory professionals is not a new story in diagnosis and healthcare. As with the increased burden of chronic diseases, the aging population and the development of healthcare insurance have increased the demand for healthcare laboratory professionals. Another reason is the lack of training sessions for the professionals.
Factors such as the retention rate, workload, and lack of certification are reasons for the lack of trained laboratory human resources, lack of education, and a relevant degree. These factors hamper the growth of the North America critical care equipment market.
- High cost of equipment
Equipment is needed for medical purposes in every department, such as surgery, orthopedics, chest medicines, and others. Mechanical equipment such as ventilators is required for external breathing support for the patients. Also, the major cost of the equipment depends upon its maintenance.
According to the Supervasi Foundation, one-day expenditure of the price of an ICU unit in India is around USD 67.17 per day, including highly-trained medical professionals. Moreover, ideally, the ICU department should comprise around 2 to 5 pieces of critical care equipment in each hospital, but due to the high cost of the equipment systems and high maintenance cost of the units in poor economic countries or rural areas hampers the growth
Opportunity
-
Growth in healthcare expenditure
Growing healthcare infrastructure helps provide better critical care, leading to faster recovery and rehabilitation into normal life. Also, as an investment in healthcare increases, more people are getting aware and desire advanced critical care equipment and diagnosing their health for precaution and cure.
Increasing healthcare expenditure for critical care treatment also helps patients to take hassle-free advanced treatment for better diagnosis and fast recovery. The spending on health is made up of self-pay or the combination of government expenditure by welfare schemes and sources, including health insurance and activities by non-governmental organizations, due to which faster recovery and rehabilitation into normal life is acting as an opportunity for growing the demand of the market.
An increase in healthcare expenditure leads to the implementation of advanced technologies equipment & products, and better treatment for critical care patients, leading to faster recovery. For this reason, faster recovery and rehabilitation into a normal life are expected to act as an opportunity for growing the demand for the North America critical care equipment market.
-
Rise in technical developments in equipments
Critical care has always been a technology- and data-dependent field. As big data and technology potentially revolutionize critical care practice, professional societies are well-positioned to partner with patients, families, practitioners, researchers, industry leaders, policymakers, and administrators to ensure that humanistic, high-value, ever-improving patient care remains the central goal for the future of critical care medicine.
Recent technological innovations are the predicted speculation about the future of critical care. The rising technical developments in critical care will continue to be multi-professional, with diverse generalists, therapists, specialists, and subspecialists seamlessly collaborating toward the common goal of optimal and humanistic patient care in a learning healthcare system. The wearable technology will optimize staffing patterns by tracking and mitigating excessive workloads while monitoring for mental and physical fatigue and distraction that could worsen patient care
Challenge
- Healthcare staff shortages
Maintaining appropriate staffing in healthcare facilities is essential for providing a safe work environment for patient care. When staffing shortages are anticipated, healthcare facilities and employers, in collaboration with human resources and occupational health services, use contingency capacity strategies to plan and prepare for mitigating the problems, such as adjusting staff schedules, hiring additional skilled staff, and rotating positions that support patient care activities.
The healthcare staff and nursing profession continue to face shortages due to a lack of potential educators, high turnover, and inequitable workforce distribution. The causes of the nursing shortage are numerous, and issues of concern are that some regions have a surplus of nurses and lower growth potential while others struggle to fulfill the local population's basic needs.
Post-COVID-19 Impact on North America Critical Care Equipment Market
Growth in the incidence of COVID-19 patients anticipated to propel the demand for medical devices such as ventilators, spirometers, oxygen concentrators, anesthesia machines, CPAP/BIPAP, and others. Moreover, advancement in technology acts as a driver for its growth in the market. However, the high cost of the devices and the risk associated with the use of ventilators act as a restraint to its growth in the market.
Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launches, and strategic partnerships to improve the technology and test results involved in the North America critical care equipment market.
Recent Developments
- В сентябре 2021 года компания SensaCore объявила о выпуске анализатора газов крови ST-200 CC Ultra Smart, который является передовой моделью Sensacore для анализа газов крови. Это полностью автоматизированная система измерения электролитов с микропроцессорным управлением, которая использует технологию прямого измерения тока с помощью ион-селективного электрода (ISE), импеданса (Hct) и амперометрии (pO2) для проведения анализа газов артериальной крови и измерения электролитов.
- В августе 2021 года компания Dixion distribution of medical devices GMBH объявила об успешном завершении регистрации в FDA. Первая серия оборудования, а именно Operating Tables Surgery и Surgical Lights Convelar, получила сертификаты FDA в дополнение к уже существующему сертификату CE.
Масштаб рынка оборудования для интенсивной терапии в Северной Америке
Рынок оборудования для интенсивной терапии в Северной Америке сегментирован по типу продукта, популяции пациентов, конечному пользователю и каналу сбыта. Рост среди сегментов помогает вам анализировать нишевые карманы роста и стратегии выхода на рынок, а также определять основные области применения и разницу в ваших целевых рынках.
ПО ТИПУ ПРОДУКТА
- Терапевтические устройства
- Устройства мониторинга состояния пациента
- Диагностические приборы
- Блоки и системы интенсивной терапии
- Другие устройства
По типу продукции рынок оборудования для интенсивной терапии в Северной Америке сегментируется на терапевтические устройства, устройства для мониторинга состояния пациентов, диагностические устройства, системы и блоки интенсивной терапии и другие устройства.
ПО КОНТЕНТУ ПАЦИЕНТОВ
- Неонатальный
- Педиатрический
- Взрослые
- гериатрический
В зависимости от численности пациентов рынок оборудования для интенсивной терапии в Северной Америке сегментируется на неонатальное, педиатрическое, взрослое и гериатрическое.
КОНЕЧНЫМ ПОЛЬЗОВАТЕЛЕМ
- Больницы
- Специализированные клиники
- Амбулаторные хирургические центры
- Другие
По типу конечного пользователя рынок оборудования для интенсивной терапии в Северной Америке сегментируется на больницы, специализированные клиники, амбулаторные хирургические центры и другие.
ПО КАНАЛУ РАСПРОСТРАНЕНИЯ
- Прямой тендер
- Розничные продажи
- Распространение третьей стороной
- Другие
По каналам сбыта рынок оборудования для интенсивной терапии в Северной Америке сегментируется на прямые торги, розничные продажи, стороннюю дистрибуцию и другие.
Региональный анализ/информация о рынке оборудования для интенсивной терапии в Северной Америке
Проведен анализ рынка оборудования для интенсивной терапии в Северной Америке, а также предоставлена информация о размере рынка, типе продукта, популяции пациентов, конечном пользователе и канале сбыта.
В данном отчете о рынке рассматриваются следующие страны: США, Канада и Мексика.
- Ожидается, что в 2023 году США будут доминировать на рынке оборудования для интенсивной терапии в Северной Америке из-за присутствия ключевых игроков на крупнейшем потребительском рынке с высоким ВВП. Ожидается, что он будет расти за счет новых технологических достижений на рынке оборудования для интенсивной терапии.
Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании на внутреннем рынке, которые влияют на текущие и будущие тенденции рынка. Такие данные, как новые продажи, заменяющие продажи, демографические данные страны, нормативные акты и импортно-экспортные тарифы, являются одними из основных указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по стране учитываются наличие и доступность брендов Северной Америки и их проблемы, связанные с большой или малой конкуренцией со стороны местных и отечественных брендов, а также влияние каналов продаж.
Конкурентная среда и анализ доли рынка оборудования для интенсивной терапии в Северной Америке
Конкурентная среда рынка оборудования для интенсивной терапии в Северной Америке содержит сведения по конкурентам. Включены сведения о компании, ее финансах, полученном доходе, рыночном потенциале, инвестициях в НИОКР, новых рыночных инициативах, производственных площадках и объектах, сильных и слабых сторонах компании, запуске продукта, одобрении продукта, патентах, широте и широте продукта, доминировании приложений и кривой жизненной линии технологий. Приведенные выше данные относятся только к фокусу компании на рынке оборудования для интенсивной терапии в Северной Америке.
Некоторые из основных игроков, работающих на североамериканском рынке оборудования для интенсивной терапии, включают Koninklijke Philips NV, General Electric Company, COOK MEDICAL LLC, Abbott, Medtronic, Getinge AB, heyer medical AG, Drägerwerk AG & Co. KGaA, ICU Medical, Inc., NIHON KOHDEN CORPORATION., Fresenius Medical Care AG & Co. KGaA, Skanray Technologies Ltd., Boston Scientific Corporation, STERIS, Advin Health Care, Baxter, SS TECHNOMED (P) LTD., SCHILLER, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nonin, Dixion distribution of medical devices GmbH, Masimo и Compumedics Limited и другие.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 MULTIVARIATE MODELING
2.6 PRODUCT TYPE LIFELINE CURVE
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 INDUSTRY INSIGHTS
5.1 CONCLUSION:
6 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: REGULATORY SCENARIO
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISE IN THE PREVALENCE OF CHRONIC DISORDERS
7.1.2 INCREASED NUMBER OF PATIENTS TREATED IN EMERGENCY CARE AND INTENSIVE CARE UNITS
7.1.3 INCREASE IN THE NUMBER OF PRODUCT LAUNCHES AND ADVANCE IN TECHNOLOGY.
7.1.4 RISE IN THE GERIATRIC POPULATION
7.2 RESTRAINTS
7.2.1 LACK OF SKILLED PROFESSIONALS
7.2.2 STRINGENT REGULATION FOR PRODUCT APPROVAL
7.2.3 HIGH COST OF EQUIPMENT
7.3 OPPORTUNITIES
7.3.1 GROWTH IN HEALTHCARE EXPENDITURE
7.3.2 RISE IN TECHNICAL DEVELOPMENTS IN EQUIPMENTS
7.3.3 STRATEGIC INITIATIVES BY KEY PLAYERS
7.4 CHALLENGES
7.4.1 HEALTHCARE STAFF SHORTAGES
7.4.2 LACK OF TRAINING AND IMPROPER CARE BY STAFF
8 IMPACT OF COVID-19 ON THE NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET
8.1 AFTERMATH OF COVID-19 AND THE GOVERNMENT ROLE
8.2 STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
8.3 PRICE IMPACT
8.4 IMPACT ON SUPPLY CHAIN
8.5 IMPACT ON DEMAND
8.6 CONCLUSION
9 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 THERAPEUTIC DEVICES
9.2.1 VENTILATOR
9.2.1.1 VENTILATOR, BY TYPE
9.2.1.1.1 INVASIVE
9.2.1.1.1.1 VOLUME-CYCLED VENTILATORS
9.2.1.1.1.2 PRESSURE-CYCLED VENTILATORS
9.2.1.1.1.3 CONTINUOUS POSITIVE AIRWAY PRESSURE VENTILATORS
9.2.1.1.1.4 BI-LEVEL POSITIVE AIRWAY PRESSURE VENTILATORS
9.2.1.1.1.5 FLOW-CYCLED VENTILATORS
9.2.1.1.1.6 TIME-CYCLED VENTILATORS
9.2.1.1.2 NON-INVASIVE
9.2.1.1.2.1 CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP)
9.2.1.1.2.2 AUTOTITRATING (ADJUSTABLE) POSITIVE AIRWAY PRESSURE (APAP)
9.2.1.1.2.3 BILEVEL POSITIVE AIRWAY PRESSURE (BIPAP)
9.2.1.2 VENTILATOR, BY PRODUCT
9.2.1.2.1 HIGH-END VENTILATORS
9.2.1.2.2 BASIC VENTILATORS
9.2.1.2.3 MID-END VENTILATORS
9.2.2 DEFIBRILLATOR & SUCTION PUMP
9.2.3 PHOTOTHERAPY EQUIPMENT
9.2.4 SYRINGE PUMPS
9.3 PATIENT MONITORING DEVICES
9.3.1 CARDIAC MONITORING DEVICES
9.3.1.1 EVENT MONITORS
9.3.1.2 ECG DEVICES
9.3.1.3 IMPLANTABLE LOOP RECORDERS
9.3.2 RESPIRATORY MONITORING DEVICES
9.3.2.1 PULSE OXIMETERS
9.3.2.2 SPIROMETERS
9.3.2.3 CAPNOGRAPHS
9.3.2.4 PEAK FLOW METERS
9.3.3 NEUROMONITORING DEVICES
9.3.3.1 ELECTROENCEPHALOGRAPH MACHINES
9.3.3.2 ELECTROMYOGRAPHY MACHINE
9.3.3.3 MAGNETOENCEPHALOGRAPH MACHINES
9.3.3.4 CEREBRAL OXIMETERS
9.3.3.5 INTRACRANIAL PRESSURE MONITORS
9.3.3.6 TRANSCRANIAL DOPPLER MACHINES
9.3.4 TEMPERATURE MONITORING DEVICES
9.3.4.1 HANDHELD TEMPERATURE MONITORING DEVICES
9.3.4.2 TABLE-TOP TEMPERATURE MONITORING DEVICES
9.3.4.3 INVASIVE TEMPERATURE MONITORING DEVICES
9.3.5 HEMODYNAMIC/PRESSURE MONITORING DEVICES
9.3.5.1 HEMODYNAMIC MONITORS
9.3.5.2 BLOOD PRESSURE MONITORING DEVICES
9.3.5.3 DISPOSABLES
9.3.6 MULTI-PARAMETER MONITORING DEVICES
9.3.6.1 HIGH-ACUITY MONITORING DEVICES
9.3.6.2 LOW-ACUITY MONITORING DEVICES
9.3.6.3 MID-ACUITY MONITORING DEVICES
9.4 DIAGNOSTIC DEVICES
9.4.1 ELECTROCARDIOGRAM (ECG) MACHINE
9.4.2 MOBILE X-RAY MACHINE
9.4.3 ULTRASONOGRAPHY MACHINE
9.4.4 ABG MACHINE
9.5 ICU UNITS & SYSTEMS
9.5.1 MEDICAL SUPPLY SYSTEMS
9.5.1.1 CEILING SUPPLY UNITS
9.5.1.2 WALL-MOUNT SUPPLY UNITS
9.5.2 SURGICAL AND EXAMINATION LIGHTS
9.5.2.1 SURGICAL LIGHT
9.5.2.2 EXAMINATION LIGHT
9.5.3 OTHERS
9.6 OTHER DEVICES
9.6.1 MEDICAL ACCESSORIES AND CONSUMABLES
9.6.1.1 CATHETERS
9.6.1.2 ECG LEADS
9.6.1.3 BABYFLOW PLUS
9.6.1.4 ANESTHESIA CIRCUIT KITS
9.6.1.5 POSITIVE AIRWAYS PRESSURE (PAP) SYSTEM
9.6.1.6 OTHERS
9.6.2 INFANT WARMERS & INCUBATORS
9.6.2.1 NICU WARMERS
9.6.2.2 TRANSPORT INCUBATOR
9.6.2.3 LABOR AND DELIVERY WARMER
9.6.3 INFUSION PUMP
9.6.4 ANESTHESIA MACHINE
9.6.5 BLOOD WARMER
9.6.6 SLEEP APNEA DEVICES
9.6.7 OTHERS
10 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY PATIENT POPULATION
10.1 OVERVIEW
10.2 NEONATAL
10.3 PEDIATRIC
10.4 GERIATRIC
10.5 ADULTS
11 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.2.1 ACUTE CARE HOSPITALS
11.2.2 LONG TERM CARE HOSPITALS
11.3 SPECIALTY CLINICS
11.4 AMBULATORY SURGICAL CENTRES
11.5 OTHERS
12 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 RETAIL SALES
12.3 DIRECT TENDER
12.4 THIRD PARTY DISTRIBUTION
12.5 OTHERS
13 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 KONINKLIJKE PHILIPS N.V.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 ABBOTT
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 GENERAL ELECTRIC COMPANY
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 BAXTER
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 MEDTRONIC
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 ADVIN HEALTH CARE
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 BOSTON SCIENTIFIC CORPORATION
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 COMPUMEDICS LIMITED
16.8.1 COMPANY SNAPSHOT
16.8.2 REVENUE ANALYSIS
16.8.3 PRODUCT PORTFOLIO
16.8.4 RECENT DEVELOPMENTS
16.9 COOK
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 DRÄGERWERK AG & CO. KGAA.
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENTS
16.11 DIXION DISTRIBUTION OF MEDICAL DEVICES GMBH
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 FRESENIUS SE & CO. KGAA
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENT
16.13 GETING AB
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENTS
16.14 HEYER MEDICAL AG
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 ICU MEDICAL
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 MASIMO
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS.
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 NIHON KOHDEN CORPORATION
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 PRODUCT PORTFOLIO
16.17.4 RECENT DEVELOPMENT
16.18 NONIN
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 STERIS
16.19.1 COMPANY SNAPSHOT
16.19.2 REVENUE ANALYSIS
16.19.3 PRODUCT PORTFOLIO
16.19.4 RECENT DEVELOPMENTS
16.2 SKANRAY TECHNOLOGIES INC
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
16.21 SS TECHNOMED (P) LTD.
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENTS
16.22 SCHILLER
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
16.23 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
Список таблиц
TABLE 1 RESPIRATORY DISEASES WORLDWIDE HEALTH BURDEN IN 2019
TABLE 2 PRICES OF A FEW VENTILATORS
TABLE 3 AVERAGE DAILY COST FOR STAY IN ICU BY HOSPITAL TYPE, 2013–2014
TABLE 4 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA NON-INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA PATIENT MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA PATIENT MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA ICU UNITS & SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA ICU UNITS & SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA NEONATAL IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA PEDIATRIC IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA GERIATRIC IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 NORTH AMERICA ADULTS IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 35 NORTH AMERICA HOSPITALS IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 NORTH AMERICA HOSPITALS IN CRITICAL CARE EQUIPMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 37 NORTH AMERICA SPECIALTY CLINICS IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 NORTH AMERICA AMBULATORY SURGICAL CENTRES IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 NORTH AMERICA OTHERS IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 NORTH AMERICA RETAIL SALES IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 NORTH AMERICA DIRECT TENDER IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 NORTH AMERICA THIRD PARTY DISTRIBUTION IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 44 NORTH AMERICA OTHERS IN CRITICAL CARE EQUIPMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 46 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 47 NORTH AMERICA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 48 NORTH AMERICA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 49 NORTH AMERICA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 50 NORTH AMERICA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 51 NORTH AMERICA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 52 NORTH AMERICA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 53 NORTH AMERICA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 54 NORTH AMERICA INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 55 NORTH AMERICA NON-INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 56 NORTH AMERICA PATIENT MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 57 NORTH AMERICA CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 58 NORTH AMERICA CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 59 NORTH AMERICA CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 60 NORTH AMERICA RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 61 NORTH AMERICA RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 62 NORTH AMERICA RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 63 NORTH AMERICA NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 NORTH AMERICA NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 65 NORTH AMERICA NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 66 NORTH AMERICA TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 67 NORTH AMERICA TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 68 NORTH AMERICA TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 69 NORTH AMERICA HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 70 NORTH AMERICA HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 71 NORTH AMERICA HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 72 NORTH AMERICA MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 73 NORTH AMERICA MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 74 NORTH AMERICA MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 75 NORTH AMERICA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 NORTH AMERICA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 77 NORTH AMERICA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 78 NORTH AMERICA ICU UNITS & SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 NORTH AMERICA MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 80 NORTH AMERICA MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 81 NORTH AMERICA MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 82 NORTH AMERICA SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 83 NORTH AMERICA SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 84 NORTH AMERICA SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 85 NORTH AMERICA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 86 NORTH AMERICA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 87 NORTH AMERICA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 88 NORTH AMERICA MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 89 NORTH AMERICA MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 90 NORTH AMERICA MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 91 NORTH AMERICA INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 92 NORTH AMERICA INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 93 NORTH AMERICA INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 94 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 95 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 96 NORTH AMERICA HOSPITALS IN CRITICAL CARE EQUIPMENT MARKET, BY END USER 2021-2030 (USD MILLION)
TABLE 97 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 98 U.S. CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 99 U.S. THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 100 U.S. THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 101 U.S. THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 102 U.S. VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 103 U.S. VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 104 U.S. VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 105 U.S. VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 106 U.S. INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 107 U.S. NON-INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 108 U.S. PATIENT MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 109 U.S. CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 110 U.S. CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 111 U.S. CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 112 U.S. RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 113 U.S. RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 114 U.S. RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 115 U.S. NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 116 U.S. NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 117 U.S. NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 118 U.S. TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 U.S. TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 120 U.S. TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 121 U.S. HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 U.S. HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 123 U.S. HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 124 U.S. HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 125 U.S. MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 126 U.S. MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 127 U.S. MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 128 U.S. DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 129 U.S. DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 130 U.S. DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 131 U.S. ICU UNITS & SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 132 U.S. MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 133 U.S. MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 134 U.S. MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 135 U.S. SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 U.S. SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 137 U.S. SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 138 U.S. OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 U.S. OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 140 U.S. OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 141 U.S. MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 142 U.S. MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 143 U.S. MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 144 U.S. INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 145 U.S. INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 146 U.S. INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 147 U.S. CRITICAL CARE EQUIPMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 148 U.S. CRITICAL CARE EQUIPMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 149 U.S. HOSPITALS IN CRITICAL CARE EQUIPMENT MARKET, BY END USER 2021-2030 (USD MILLION)
TABLE 150 U.S. CRITICAL CARE EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 151 CANADA CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 152 CANADA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 153 CANADA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 154 CANADA THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 155 U.S. VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 156 CANADA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 157 CANADA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 158 CANADA VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 159 CANADA INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 160 CANADA NON-INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 161 CANADA PATIENT MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 162 CANADA CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 163 CANADA CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 164 CANADA CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 165 CANADA RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 166 CANADA RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 167 CANADA RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 168 CANADA NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 169 CANADA NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 170 CANADA NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 171 CANADA TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 172 CANADA TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 173 CANADA TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 174 CANADA HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 175 CANADA HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 176 CANADA HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 177 CANADA MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 178 CANADA MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 179 CANADA MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 180 CANADA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 181 CANADA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 182 CANADA DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 183 CANADA ICU UNITS & SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 184 CANADA MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 185 CANADA MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 186 CANADA MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 187 CANADA SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 188 CANADA SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 189 CANADA SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 190 CANADA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 191 CANADA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 192 CANADA OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 193 CANADA MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 194 CANADA MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 195 CANADA MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 196 CANADA INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 197 CANADA INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 198 CANADA INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 199 CANADA CRITICAL CARE EQUIPMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 200 CANADA CRITICAL CARE EQUIPMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 201 CANADA HOSPITALS IN CRITICAL CARE EQUIPMENT MARKET, BY END USER 2021-2030 (USD MILLION)
TABLE 202 CANADA CRITICAL CARE EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 203 MEXICO CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 MEXICO THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 205 MEXICO THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 206 MEXICO THERAPEUTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 207 MEXICO VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 208 MEXICO VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 209 MEXICO VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 210 MEXICO VENTILATOR IN CRITICAL CARE EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 211 MEXICO INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 MEXICO NON-INVASIVE IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 213 MEXICO PATIENT MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 214 MEXICO CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 MEXICO CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 216 MEXICO CARDIAC MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 217 MEXICO RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 MEXICO RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 219 MEXICO RESPIRATORY MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 220 MEXICO NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 221 MEXICO NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 222 MEXICO NEUROMONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 223 MEXICO TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 224 MEXICO TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 225 MEXICO TEMPERATURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 226 MEXICO HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 227 MEXICO HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 228 MEXICO HEMODYNAMIC/PRESSURE MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 229 MEXICO MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 230 MEXICO MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 231 MEXICO MULTI-PARAMETER MONITORING DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 232 MEXICO DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 233 MEXICO DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 234 MEXICO DIAGNOSTIC DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 235 MEXICO ICU UNITS & SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 236 MEXICO MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 237 MEXICO MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 238 MEXICO MEDICAL SUPPLY SYSTEMS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 239 MEXICO SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 240 MEXICO SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 241 MEXICO SURGICAL AND EXAMINATION LIGHTS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 242 MEXICO OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 243 MEXICO OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 244 MEXICO OTHER DEVICES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 245 MEXICO MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 246 MEXICO MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 247 MEXICO MEDICAL ACCESSORIES AND CONSUMABLES IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 248 MEXICO INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 249 MEXICO INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 250 MEXICO INFANT WARMERS & INCUBATORS IN CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 251 MEXICO CRITICAL CARE EQUIPMENT MARKET, BY PATIENT POPULATION, 2021-2030 (USD MILLION)
TABLE 252 MEXICO CRITICAL CARE EQUIPMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 253 MEXICO HOSPITALS IN CRITICAL CARE EQUIPMENT MARKET, BY END USER 2021-2030 (USD MILLION)
TABLE 254 MEXICO CRITICAL CARE EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
Список рисунков
FIGURE 1 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: NORTH AMERICA VS. REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: SEGMENTATION
FIGURE 12 INCREASING CHRONIC DISORDERS AND THE NUMBER OF PATIENT IN ICU AND NICU IS EXPECTED TO DRIVE THE NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 13 THERAPEUTIC DEVICES IS EXPECTED TO HAVE THE LARGEST SHARE OF NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET FROM 2023 TO 2030
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET
FIGURE 15 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PRODUCT TYPE, 2022
FIGURE 16 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 17 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 18 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 19 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PATIENT POPULATION, 2022
FIGURE 20 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PATIENT POPULATION, 2023-2030 (USD MILLION)
FIGURE 21 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PATIENT POPULATION, CAGR (2023-2030)
FIGURE 22 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY PATIENT POPULATION, LIFELINE CURVE
FIGURE 23 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY END USER, 2022
FIGURE 24 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 25 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY END USER, CAGR (2023-2030)
FIGURE 26 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 27 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 28 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 29 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 30 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 31 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: SNAPSHOT (2022)
FIGURE 32 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY COUNTRY (2022)
FIGURE 33 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY COUNTRY (2023 & 2030)
FIGURE 34 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: BY COUNTRY (2022 & 2030)
FIGURE 35 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: PRODUCT TYPE (2023-2030)
FIGURE 36 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET: COMPANY SHARE 2022 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
